What is Subcutaneous immune globulin?
Category: Prescription Drugs
Most popular types: Hizentra HyQvia CUVITRU Show all
Subcutaneous immune globulin is used in the treatment of primary humoral immunodeficiency.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Common variable immune deficiency | 30 | 26 | |
| Hypogammaglobulinemia | 14 | 16 | |
| Chronic inflammatory demyelinating polyneuropathy | 5 | 10 | |
| IgG deficiency | 3 | 2 | |
| Specific antibody deficiency | 3 | 1 | |
| Lyme disease | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 2 | |
| Moderate | 11 | |
| Mild | 32 | |
| None | 9 |
Commonly reported side effects and conditions associated with Subcutaneous immune globulin
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 5 | |
| Injection site pain | 5 | |
| Injection site swelling | 5 | |
| Headaches | 3 | |
| Chills | 2 | |
| Diarrhea | 2 |
Duration
Stopped taking Subcutaneous immune globulin
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 | |
| 1 - 6 months | 1 | |
| 2 - 5 years | 2 |
What people switch to and from
Patients started taking Subcutaneous immune globulin after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) | 18 | |
| Subcutaneous immune globulin (Hizentra) | 2 | |
| Cutaquig | 1 |
Patients stopped taking Subcutaneous immune globulin and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) | 5 | |
| Subcutaneous immune globulin (Hizentra) | 2 | |
| Cutaquig | 1 |
Last updated: